Epidemiology and molecular characterization of vancomycin resistant Enterococci isolates in India

References

• National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992 to June 2003, issued August 2003. Am J Infect Control 2003;31:481–98.
   PubMed Web of Science ®Google Scholar
• Depardieu F, Bonora MG, Reynolds PE, Courvalin P. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Molecular Microbiol 2003; 50: 931–48
   PubMed Web of Science ®Google Scholar
• Tornieporth NG, Roberts RB, John J, Hafnier A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767–72
   PubMed Web of Science ®Google Scholar
• Wells CL, Juni BA, Cameron SB, Mason KR, Dunn DL, Fernieri P, et al. Stool carriage, clinical isolation and mortality during an outbreak of vancomycin resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995; 21: 45–50
   PubMed Web of Science ®Google Scholar
• Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendation for preventing the spread of vancomycin resistance Infect Control Hosp Epidemiol 1995;16:105–13.
   PubMed Web of Science ®Google Scholar
• Mathur P, Kapil A, Chandra R, Sharma P, Das B. Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res 2003; 118: 25–8
   PubMedGoogle Scholar
• Randhawa VS, Kapoor L, Singh V, Mehta G. Aminoglycoside resistance in enterococci isolated from paediatric septicaemia in a tertiary care hospital in north India. Indian J Med Res 2004; 119: 77–9
   PubMedGoogle Scholar
• Taneja N, Rani P, Emmanuel R, Sharma M. Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in northern India. Indian J Med Res 2004; 119: 72–4
   PubMedGoogle Scholar
• Taneja N, Emmanuel R, Chari PS, Sharma M. A prospective study of hospital acquired infections in burn patients at a tertiary care referral centre in north India. Burns 2004; 30: 665–9
   PubMedGoogle Scholar
• Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989; 27: 731–4
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 5th edn. Performance standards for antimicrobial susceptibility testing; 2000. M7-A5.
   Google Scholar
• Bell JM, Paton JC, Turnidge J. Emergence of vancomycin resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187–90
   PubMed Web of Science ®Google Scholar
• Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993; 37: 2311–7
   PubMed Web of Science ®Google Scholar
• Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24–7
   PubMed Web of Science ®Google Scholar
• Lu JJ, Perng CL, Chiueh TS, Lee SY, Chen CH, Chang FY, et al. Detection and typing of vancomycin resistance genes of enterococci from clinical and nosocomial surveillance specimens by multiplex PCR. Epidemiol Infect 2001; 126: 357–63
   PubMedGoogle Scholar
• Vandamme P, Vercauteren E, Lammens C, Pensart N, Ieven M, Pot B, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572–6
   PubMed Web of Science ®Google Scholar
• Green M, Barbadora K, Michaels M. Recovery of vancomycin resistant Gram-positive cocci from paediatric liver transplant recipients. J Clin Microbiol 1991; 29: 2503–6
   PubMed Web of Science ®Google Scholar
• Lu JJ, Wu JC, Chiueh TS, Perng CL, Chi WM, Lee WH. Characterization of a highly glycopeptide resistant Enterococcus gallinarum isolate. J Formos Med Assoc 2000; 99: 305–10
   PubMedGoogle Scholar
• Dutka-Malen S, Blaimont B, Wauters G, Courvalin P. Emergence of high-level resistance to glycopetides in Enterococcus gallinarum and Enterococcus casselifavus. Antimicrob Agents Chemother 1994; 38: 1675–7
   PubMed Web of Science ®Google Scholar
• Cetinkaya Y, Falk P, Mayhall CG. Vancomycin resistant enterococci. Clin Microbiol Rev 2000; 13: 686–7
   PubMed Web of Science ®Google Scholar
• Dahms RA, Johnson EM, Statz CL, Lee JT, Dunn DL, Beilman GJ. Third generation cephalosporins and vancomycin as risk factors for postoperative vancomycin resistant Enterococcus infection. Arch Surg 1998; 133: 1343–6
   PubMedGoogle Scholar
• Beltrami EM, Singer DA, Fish L, Manning K, Young S, Banerjee SN, et al. Risk factors for acquisition of vancomycin resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control 2000; 28: 282–5
   PubMedGoogle Scholar
• Humphreys H, Dolan V, Sexton T, Conlon P, Rajan L, Creamer E, et al. Implications of colonization of vancomycin resistant enterococci (VRE) in renal dialysis patients. Learning to live with it?. J Hosp Infect. 2004; 58: 28–33
   PubMedGoogle Scholar
• Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin resistant Enterococcus. Emerg Infect Dis 2002; 8: 802–7
   PubMed Web of Science ®Google Scholar
• Padiglione AA, Wolfe R, Grabsch EA, Olden D, Pearson S, Franklin C, et al. Risk factors for new detection of vancomycin resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 2003; 47: 2492–8
   PubMedGoogle Scholar
• Morrison A, Wenzel RP. Nosocomial urinary tract infections due to Enterococcus. 10-y experience at a university hospital. Arch Intern Med 1986; 146: 1549–51
   PubMedGoogle Scholar